Trials / Completed
CompletedNCT00905580
Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that pregabalin will decrease post-operative pain scores and analgesic use following robot-assisted endoscopic thyroidectomy compared to placebo. The primary outcome will be acute postoperative pain, measured by a verbal numerical rating score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary outcome will be the incidence of chronic pain and hypoesthesia in the anterior chest at 3 months after operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | Pregabalin 150 mg orally |
| DRUG | Vitamin Complex (placebo) | Vitamin Complex 150 mg orally |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-05-20
- Last updated
- 2010-01-20
- Results posted
- 2010-01-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00905580. Inclusion in this directory is not an endorsement.